INTRODUCTION
The transport of lactate and other monocarboxylic acids such a pyruvate, ,-hydroxybutyrate and acetoacetate across the plasma membrane is of major physiological importance to most mammalian cells. Indeed, almost all cells possess a H+-monocarboxylate cotransporter which is responsible for this process (for a recent review, see Poole and Halestrap, 1993) . Mono- carboxylate transport has been studied most extensively in erythrocytes, where it is stereoselective for L-over D-lactate, and sensitive to inhibition by derivatives of a-cyanocinnamate, organomercurial thiol reagents, and some stilbene disulphonates (Halestrap, 1976; Deuticke et al., 1978; Poole and Halestrap, 1991) . Other cell types possess similar cyanocinnamate-sensitive proton-linked monocarboxylate transporters, and there is increasing evidence for a family of such carriers with different substrate and inhibitor selectivities (Poole and Halestrap, 1993) .
Attempts to identify the protein responsible for transport of lactate in erythrocytes have used approaches based upon either chemical labelling or solubilization, fractionation and functional reconstitution (Jennings and Adams-Lackey, 1982 ; Halestrap, 1988, 1992) . Jennings and Adams-Lackey (1982) were the first to demonstrate irreversible inhibition of lactate transport by 4,4'-diisothiocyanodihydrostilbene-2,2'-disulphonate (H2DIDS) and labelling of a protein of 40-50 kDa in rabbit erythrocytes by 3H2DIDS in parallel with inhibition of transport. However, the specificity of this labelling was difficult to assess (see Poole and Halestrap, 1992) . More recently we demonstrated that both the stilbene disulphonate 4,4'-diisothiocyanostilbene-2,2'-disulphonate (DIDS) and its dihydro-derivative H2DIDS are affinity labels for the transporter (Poole and Halestrap, 1991 (Poole and Halestrap, 1992) . Furthermore, inhibitors [e.g. a-cyano-4-hydroxycinnamate (CHC)] and substrates of the transporter protected against labelling of the rabbit and rat proteins by DIDS in precisely the manner expected. Only those stilbene disulphonates which were potent inhibitors of lactate transport were effective inhibitors of the labelling of the rabbit 40-50 kDa protein (Poole and Halestrap, 1992) . Additionally, fractionation of monocarboxylate transport activity from rat erythrocytes, monitored after reconstitution into lipid vesicles, revealed copurification of activity with the DIDS-labelled protein (Poole and Halestrap, 1992) .
Recently the cDNA encoding a mutant protein (MEV) which transports mevalonic acid (a 6-carbon monocarboxylate) has been cloned from a Chinese hamster ovary (CHO) cell variant (Kim et al., 1992 (Kim et al., 1992) . The transport of mevalonate by the CHO cell variant was also inhibited by DIDS, in the same concentration range that inhibits lactate transport (Faust and Krieger, 1987) . In the present work we present an improved purification of the rabbit erythrocyte lactate transporter and N-terminal protein sequence of the DIDS-labelled carrier. These data show that lactate Abbreviations used: DIDS, 4,4'-diisothiocyanostilbene-2,2'-disulphonate; H2DIDS, 4,4'-diisothiocyanodihydrostilbene-2,2'-disulphonate; DBDS, 4,4'-dibenzamidostilbene-2,2'-disulphonate; DNDS, 4,4'-dinitrostilbene-2,2'-disulphonate; CHC, a-cyano-4-hydroxycinnamate; MEGA-10, decanoyl-N-transport in erythrocytes is almost certainly mediated by the wild-type form of MEV. After completion of our studies, Kim Garcia et al. (1994) reported that expression of the wild-type form of MEV in a human breast carcinoma cell line does indeed lead to enhanced transport of lactate and other monocarboxylates, and named the carrier MCT1 (monocarboxylate transporter 1).
MATERIALS
All chemicals, biochemicals and radiochemicals were obtained from the sources given previously Halestrap, 1991, 1992) , with the following additions. The detergent octaethyleneglycol monododecylether (C12E8) was obtained from Fluka, Glossop, Derbyshire, U.K. and mevalonic lactone from Aldrich Chemical Co., Gillingham, Dorset, U.K. Solutions of sodium mevalonate (1 M) were prepared by alkaline hydrolysis of the lactone (Brown et al., 1978) , as follows. Mevalonic lactone was dissolved in water and treated with a 0.2 molar excess of NaOH at 50°C for 60 min, adjusted to pH 8.0 prior to storage at -20 'C. Purified N-glycanase F was obtained from Oxford Glycosystems. Aminoethyl-Sepharose was prepared from cyanogen bromide-activated Sepharose 4B (Sigma Chemical Co., Poole, Dorset, U.K.) as described by Casey et al. (1989) . (Poole and Halestrap, 1991) . The cells were washed free of reversibly bound inhibitor in citrate buffer +0.50% (w/v) BSA before preparation of membranes by hypotonic lysis and storage at -70°C (Poole and Halestrap, 1992) . All subsequent steps were performed at 4-7°C in a buffer (pH 7.4) containing 20 mM Mops, 1 mM EGTA, 0.2 mM dithiothreitol and 1 ,tg/ml of each of the proteinase inhibitors pepstatin, antipain and leupeptin. In most experiments the buffer also included 1 mM Na-pyruvate. Erythrocyte membranes were thawed and sedimented by centrifugation at 30000 g for 10 min at 4°C, and stripped of peripheral membrane proteins by treatment with approx. 10 volumes of ice-cold reconstitution buffer containing 1 M KI and 0.5 mM phenylmethylsulphonyl fluoride (PMSF). The stripped membranes were collected by centrifugation at 30 000 g for 15 min at 4°C, and washed once more in buffer. The membranes were then treated with approx. 5 volumes of buffer containing 0.05 % (w/v) C12E8, a treatment which is known to extract sialoglycoproteins selectively (Yu et al., 1973) . The membranes were sedimented and washed once more, before solubilization at a protein concentration of 2 mg/ml with 1 % (w/v) C12E8, in the presence of 1 mM PMSF. After centrifugation at 30000 g for 30 min at 4°C, the supernatant was applied to an aminoethyl-Sepharose column equilibrated with buffer containing 0.1 0% C12E8, attached to a Pharmacia f.p.l.c. system. After removal of non-bound protein, elution was performed by increasing the concentration of NaCl in the buffer. The DIDS-iabelled 40-50 kDa protein was followed through purification by Western blotting of fractions with an anti-DIDS antibody, using the procedures described previously to reduce the background immunoreactivity (Poole and Halestrap, 1992). Immunoblots were developed using the enhanced chemiluminescence system (ECL, Amersham International p.l.c, U.K.). The peak fractions containing the DIDS-labelled transporter were concentrated, usually by chromatography on a Mono-Q HR5/5 ion-exchange column equilibrated with buffer containing 0.2% C12E8. The protein was eluted with a steep 0-1.0 M NaCl gradient, and desalted by passage through a PD-10 gel filtration column (Pharmacia) equilibrated with 0.1 % C12E8. If further concentration was required, this was performed by centrifugal filtration using a Centricon 10 (Amicon). The concentrated protein was stored at -20°C until use.
METHODS
Preparation of the lactate transporter for N-terminal microsequencing A sample of the purified 40-50 kDa DIDS-labelled transporter (approx. 100 ,ug) was treated with 60 Oxford Glycosystems units of N-glycanase F for approx. 3 h at 37°C, and subjected to SDS/PAGE on a 10% (w/v) polyacrylamide gel. The protein was electroblotted onto a ProBlot membrane (Applied Biosystems) and stained with Serva Blue G. The broad 40-50 kDa band, which stained poorly with this dye, was excised as upper and lower halves and each was subjected to N-terminal microsequencing using an Applied Biosystems 477A pulsed liquid protein sequencer.
Measurement of monocarboxylate transport
Zero-trans uptake of 0.5 mM [U-'4C]-L-lactate into erythrocytes at 7°C was measured by a centrifuge-stop technique as described previously (Poole and Halestrap, 1991) . Transport was also measured by following the proton fluxes which accompany the uptake ofmonocarboxylates on the transporter, using an external pH electrode and a microcomputer for data acquisition as described previously (Poole and Halestrap, 1991) .
Analytical techniques
Protein was assayed by the dye-binding method of Bradford (1976), using BSA as standard. SDS/PAGE was performed by the method of Laemmli (1970) , with silver staining by the method of Nielsen and Brown (1984) .
RESULTS
The lactate transporter was purified from rabbit erythocytes, since immunoblots with anti-DIDS antibodies reveal particularly high levels of the labelled protein in these cells (Poole and Halestrap, 1992) . It is much easier to follow purification of the labelled protein than to follow reconstituted transport activity, as we found that this can be very labile during fractionation. A modified procedure for purification of the rabbit erythrocyte lactate transporter was developed for several reasons. Firstly, the Mono-Q ion-exchange fractionation that was successful for partial purification of the rat erythrocyte transporter failed to separate the rabbit DIDS-labelled protein from the major solubilized protein, band 3 (results not shown). Secondly, this column bound much of the protein so tightly that elution proved difficult. Finally, it is known that, at least for band 3, there is a tendency for aggregation to occur in detergents with a high critical micelle concentration (CMC), such as the decanoyl-Nmethyl glucamide (MEGA-10) employed during this procedure (Casey and Reithmeier, 1993) . We therefore used a weaker anion-exchange column (aminoethyl-Sepharose) and the detergent C12E8 which has a low CMC (approx. 0.06 mM). In Figure 1 we show the elution profile for such a chromatographic (Poole and Halestrap, 1992) . There was frequently nonspecific cross-reactivity of these antibodies, which resulted in the appearance of bands at approx. 50-60 kDa, as in Figure Ic . Such bands were even found in tracks loaded with molecular mass standards, and thus appear to be independent of DIDS-labelling. We have demonstrated previously that DIDS labelling of the proteins of 35-50 kDa from rabbit and rabbit erythrocytes is sensitive to substrates and inhibitors of lactate transport, and that the DIDS-labelled protein of this molecular mass from rat erythrocytes co-fractionates with transport activity (Poole and Halestrap, 1992 (Figure b) , and transferred to ProBlot for sequencing. Since the transporter spans a large range of molecular mass and might contain minor contaminating species, the upper and lower halves of the 40-50 kDa band were each subjected to protein sequencing. The upper band yielded a single sequence. This was also the major sequence obtained from the lower band, which also contained lower levels of ill-defined sequences(s). The absence of appreciable contaminating sequence(s) confirms the high level of purity of the 40-50 kDa transporter after gel purification. Analysis of the data gave a very clear sequence for 16 rounds of the Edman degradation (Figure 2 ). The N-terminal amino acid sequence predicted from the cDNA encoding MCT1, cloned by Kim et al. (1992) transport (extracellular alkalinization) with constant stirring in a water-ja 37 OC. These measurements were performed with 4 ml of rabbit erythrocytes in a lightly buffered citrate medium (84 mM Na-citrate/i mM EGTA, pH 7.4 DIDS and 100 ,uM acetazolamide to inhibit band-3-mediated pH changes.
(2 mM), DBDS (0.2 mM) and DNDS (0.2 mM) were added to the cell susi 5 min before addition of 10 mM Na-mevalonate or L-lactate at the time shown are means of two traces in each case.
te transporter 1990; Poole and Halestrap, 1993) . The structure of mevalonate suggested that it may be a substrate for the lactate transporter, but that it is unlikely to be transported very efficiently. This was investigated in two ways: firstly by using mevalonate as a obtained from competitive inhibitor of L-lactate transport, and secondly by ced amino acid measuring inhibitor-sensitive proton fluxes induced by mevalonate. Mevalonate caused little inhibition of L-lactate transport was performed as at concentrations up to 30 mM, indicating a very low (if any) is derived from the affinity for the transporter (data not shown). In order to measure transport of mevalonate itself, with high sensitivity, mevalonateinduced proton fluxes were measured at 37°C, a temperature where lactate transport is too fast to resolve (see Figure 3) . In these experiments uptake of mevalonate with a proton results in extracellular alkalinization. This would also occur if mevalonate diffuses across the membrane as the free acid, a process which occurs to a greater or lesser extent with all monocarboxylates. Mev + CHC However, transport on the lactate transporter, unlike diffusion, 0-1% is sensitive to inhibition by derivatives of cyanocinnamate and to Mev + DBDS some stilbene disulphonates including 4,4'-dibenzamidostilbene-2,2'-disulphonate (DBDS). In contrast others such as 4,4'-Mev + DNDS dinitrostilbene-2,2'-disulphonate (DNDS) are much less effective (Poole and Halestrap, 1991) . The data in Figure 3 demonstrate that addition of mevalonate induces proton fluxes, and that these Mev were inhibited considerably by 2 mM CHC and to a similar extent by 0. (Kim et al., 1992; Kim Garcia et al., 1994) . As shown below, mevalonate is related structurally to lactate, being an hydroxyl-substituted aliphatic monocarboxylate.
Mevalonate tH3 CH2OH-CH2-C-CH2-COO OH Lactate H
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Work from this and other laboratories has demonstrated that the lactate transporter will accept a wide range of substituted aliphatic monocarboxylates up to C-5 or C-6, although the larger compounds and those with branched hydrocarbon chains are frequently less effective substrates (Deuticke, 1982; al.,
The data we have presented here strongly suggest that the lactate carrier of rabbit erythrocytes is the rabbit equivalent of MCT1. The MCT1 protein has 12 putative transmembrane segments, with a large hydrophilic loop predicted between transmembrane segments 6 and 7. This topology is similar to that proposed for many sugar transporters (Griffith et al., 1992; Gould and Holman, 1993) , but there is no homology between these proteins at the sequence level (Kim et al., 1992) . On a search of the sequence databases (March 1994) the best overall sequence similarity we were able to find was with the ProP proline/betaine transporter from Escherichia coli (Culham et al., 1993) , for which there is 16.4 % identity in a 390 amino acid overlap. This protein is proposed to have a similar membrane topology to that predicted for MEV. There were also limited regions of sequence similarity with some transporters, including some of the Na+-and Cl--dependent neurotransmitter transporter family. The highest similarities are for the taurine (Jhiang et al., 1993) and GABA (Borden et al., 1992) transporters, for which there is approx. 30 % identity for a 62 amino acid overlap towards the Nterminus of these proteins.
There is additional information which strengthens the association of MCT1 with plasma membrane lactate transport in erythrocytes. Firstly, MCT1, like the erythrocyte lactate transporter, has an apparent molecular mass of 43 kDa on SDS/ PAGE analysis. This higher-than-predicted mobility for a protein of 494 amino acids is common for hydrophobic membrane proteins (Viitanen et al., 1986) . Secondly, transport of pyruvate by MCT1 is sensitive to inhibition by inhibitors such as DIDS and derivatives of cyanocinnamate (Kim Garcia et al., 1994) .
Finally, Northern blots also revealed expression of MEV/MCT1-related RNA in spleen, a major erythropoietic tissue in rodents (Kim et al., 1992) .
MEV, a mutant protein which transports mevalonate, is identical to MCT1 with the exception of a Phe to Cys substitation at position 360. This mutation appears to have a profound affect on substrate and inhibitor selectivity, since MEV transports pyruvate poorly if at all, and is much less sensitive to inhibition by derivatives of cyanocinnamate (Kim Garcia et al., 1994 The identification of the erythrocyte lactate transporter as MCT1 will aid future studies, since there is a wealth of information concerning the properties of the lactate transporter in these cells (kinetics, inhibition, chemical labelling) that will form a sound background for future studies of the relationship between the structure and function of MCT1, by heterologous expression of normal and mutant proteins. The erythrocyte also offers an ideal experimental system for certain studies to investigate topology of membrane proteins, since it is relatively easy to prepare sealed, leaky and inside-out preparations of membranes to perform vectorial proteolysis and antibody binding. These studies, along with those of the near-purified protein which can now be prepared with ease, can be interpreted much more readily within the context of the sequence of MCT1 which encodes this protein.
